Proto Axiom is an Australian based venture capital firm, led by successful, experienced operators, investors and former health executives.
We target breakthrough biomedical technology companies developing drugs and medical devices in APAC, leveraging our experience as builders and backers. We have a lean management team, yet comprise 29 team members and highly skilled advisors, who are scientist-entrepreneurs with knowledge across the entire supply chain.
We know first hand how to build world-class companies. Proto Axiom on-shores scientific capacity backed by leading institutional investors to keep IP in Australia.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 80 Mount St, 303,australia
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- http://www.protoaxiom.com
- HQ
- North Sydney, New South Wales
Proto Axiom Questions
Proto Axiom's website is http://www.protoaxiom.com
Proto Axiom's LinkedIn profile is https://au.linkedin.com/company/proto-axiom
Proto Axiom has
16 employees.
View email and phone details for 16
employees at Proto Axiom.
Proto Axiom's industry is
Investment Management
Proto Axiom's top competitors are
Nadmed Ltd.,
Aglow,
Decarice,
Hapana,
Pittan,
Apromore,
Endo Axiom,
Swan Genomics,
Kinoxis Therapeutics Pty Ltd,
Biomatter.
Proto Axiom's categories are Investment Management
Proto Axiom's founding year is 2021
